Calcineurin inhibitors in nephrotic syndrome secondary to podocyte gene mutations: a systematic review
Sign Up to like & getrecommendations! Published in 2020 at "Pediatric Nephrology"
DOI: 10.1007/s00467-020-04695-0
Abstract: Calcineurin inhibitor (CNI) use in genetic steroid-resistant nephrotic syndrome (SRNS) is controversial as response rate is reported to be lower than non-genetic disease and no plausible mechanism of action is known. We reviewed PubMed for… read more here.
Keywords: calcineurin inhibitors; response; inhibitors nephrotic; syndrome secondary ... See more keywords